Question 1

What specific benefits might DVS SR offer compared to my current pain management options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study Evaluating Desvenlafaxine Succinate Sustained-release (DVS SR) in Adult Outpatients With Pain Associated With Diabetic Peripheral Neuropathy clinical trial (NCT00283842). Contact the study team or your healthcare provider for specific answers.

Question 2

How will the study monitor my health and manage any side effects?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study Evaluating Desvenlafaxine Succinate Sustained-release (DVS SR) in Adult Outpatients With Pain Associated With Diabetic Peripheral Neuropathy clinical trial (NCT00283842). Contact the study team or your healthcare provider for specific answers.

Question 3

What is the expected duration of the treatment and how often will I need to visit the clinic?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study Evaluating Desvenlafaxine Succinate Sustained-release (DVS SR) in Adult Outpatients With Pain Associated With Diabetic Peripheral Neuropathy clinical trial (NCT00283842). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there any risks associated with participating in this trial that I should be aware of?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study Evaluating Desvenlafaxine Succinate Sustained-release (DVS SR) in Adult Outpatients With Pain Associated With Diabetic Peripheral Neuropathy clinical trial (NCT00283842). Contact the study team or your healthcare provider for specific answers.

Question 5

How does the placebo compare to the active treatment in terms of potential outcomes?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study Evaluating Desvenlafaxine Succinate Sustained-release (DVS SR) in Adult Outpatients With Pain Associated With Diabetic Peripheral Neuropathy clinical trial (NCT00283842). Contact the study team or your healthcare provider for specific answers.

What this study is about